MedPath

Asmanex

These highlights do not include all the information needed to use ASMANEX TWISTHALER safely and effectively. See full prescribing information for ASMANEX TWISTHALER. ASMANEX TWISTHALER 110 mcg, 220 mcg (mometasone furoate inhalation powder)Initial U.S. Approval: 1987

Approved
Approval ID

ba17a773-7f7a-4cc5-9297-359decedfed0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 13, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mometasone Furoate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-5547
Application NumberNDA021067
Product Classification
M
Marketing Category
C73594
G
Generic Name
Mometasone Furoate
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateNovember 19, 2010
FDA Product Classification

INGREDIENTS (2)

MOMETASONE FUROATEActive
Quantity: 220 ug in 1 1
Code: 04201GDN4R
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.